Accelerating the Research, Development, and Acquisition of Medical Countermeasures Against Biological Warfare Agents

Accelerating the Research, Development, and Acquisition of Medical Countermeasures Against Biological Warfare Agents

Interim Report

eBook - 2003
Rate this:
Having the means to protect its military personnel against biological warfare agents is a long-standing objective for the United States. The development of safe and effective medical countermeasures -- vaccines, antitoxins, and prophylactic and therapeutic drugs -- against those agents is one of the essential components of the nation's biological defense efforts. Currently, the United States has a limited repertoire of licensed medical countermeasures that the Department of Defense (DoD) can use to protect members of the armed forces against more than a dozen bacteria, viruses, and toxins identified as possible biological warfare agents. As part of its Chemical and Biological Defense Program, DoD is engaged in research and development efforts aimed at making available a broader range of medical countermeasures.
Publisher: Washington, DC :, The National Academies Press,, [2003]
ISBN: 9780309582599
0309582598
9781280247842
1280247843
Characteristics: 1 online resource
data file,rda

Opinion

From the critics


Community Activity

Comment

Add a Comment

There are no comments for this title yet.

Age Suitability

Add Age Suitability

There are no age suitabilities for this title yet.

Summary

Add a Summary

There are no summaries for this title yet.

Notices

Add Notices

There are no notices for this title yet.

Quotes

Add a Quote

There are no quotes for this title yet.

Explore Further

Recommendations

Subject Headings

  Loading...

Find it at WPL

  Loading...
[]
[]
To Top